DTX3L, an E3-ubiquitin ligase, is required for maintaining LIPG protein levels by inhibiting proteasome-mediated LIPG degradation, and DTX3L-LIPG-ISG15 signaling is essential for malignancies of triple-negative breast cancer cells (TNBCs) [165]. The gene discussed is LIPG; the disease is triple-negative breast carcinoma.